Healthcare provider profile · identity verified

Keith M Ratcliff, M.D.

Family Practice · WASHINGTON, MO · NPI 1841232386

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1030	318
Lisinopril	Lisinopril	356	121
Levothyroxine Sodium	Levothyroxine Sodium	308	91
Losartan Potassium	Losartan Potassium	243	88
Jardiance	Empagliflozin	226	51
Amlodipine Besylate	Amlodipine Besylate	221	71
Gabapentin	Gabapentin	190	70
Metformin Hcl	Metformin Hcl	188	74
Omeprazole	Omeprazole	188	57
Rosuvastatin Calcium	Rosuvastatin Calcium	186	70
Alendronate Sodium	Alendronate Sodium	183	47
Trazodone Hcl	Trazodone Hcl	176	51
Metoprolol Tartrate	Metoprolol Tartrate	173	43
Escitalopram Oxalate	Escitalopram Oxalate	154	36
Tramadol Hcl	Tramadol Hcl	154	28
Furosemide	Furosemide	139	43
Metoprolol Succinate	Metoprolol Succinate	136	43
Tamsulosin Hcl	Tamsulosin Hcl	135	46
Carvedilol	Carvedilol	133	41
Montelukast Sodium	Montelukast Sodium	129	36
Ezetimibe	Ezetimibe	125	48
Pantoprazole Sodium	Pantoprazole Sodium	121	39
Clopidogrel	Clopidogrel Bisulfate	106	32
Finasteride	Finasteride	105	31
Eliquis	Apixaban	102	28
Duloxetine Hcl	Duloxetine Hcl	99	28
Potassium Chloride	Potassium Chloride	97	25
Albuterol Sulfate Hfa	Albuterol Sulfate	94	44
Famotidine	Famotidine	92	30
Arexvy	Rsvpref3 Antigen/As01e/Pf	87	87
Ropinirole Hcl	Ropinirole Hcl	77	15
Sertraline Hcl	Sertraline Hcl	76	26
Mirtazapine	Mirtazapine	74	18
Xarelto	Rivaroxaban	69	15
Buspirone Hcl	Buspirone Hcl	65	22
Hydrochlorothiazide	Hydrochlorothiazide	61	25
Ozempic	Semaglutide	61	suppressed
Bupropion Xl	Bupropion Hcl	59	16
Allopurinol	Allopurinol	54	16
Venlafaxine Hcl Er	Venlafaxine Hcl	54	17
Fluticasone Propionate	Fluticasone Propionate	49	23
Pioglitazone Hcl	Pioglitazone Hcl	49	18
Metformin Hcl Er	Metformin Hcl	47	25
Vitamin D2	Ergocalciferol (Vitamin D2)	47	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	14
Memantine Hcl	Memantine Hcl	42	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	18
Naproxen	Naproxen	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Clonidine Hcl	Clonidine Hcl	38	11
Oxybutynin Chloride Er	Oxybutynin Chloride	38	15
Paliperidone Er	Paliperidone	35	suppressed
Rybelsus	Semaglutide	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	12
Farxiga	Dapagliflozin Propanediol	34	suppressed
Prednisone	Prednisone	34	19
Donepezil Hcl	Donepezil Hcl	32	12
Levetiracetam	Levetiracetam	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Meloxicam	Meloxicam	29	14
Spironolactone	Spironolactone	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	12
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Lithium Carbonate	Lithium Carbonate	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	13
Myrbetriq	Mirabegron	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Repatha Sureclick	Evolocumab	15	suppressed
Roflumilast	Roflumilast	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Risperidone	Risperidone	14	suppressed
Tradjenta	Linagliptin	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Nystop	Nystatin	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Atenolol	Atenolol	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sucralfate	Sucralfate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Cephalexin	Cephalexin	11	11
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Testosterone	Testosterone	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error